Bonilha Isabella, Hajduch Eric, Luchiari Beatriz, Nadruz Wilson, Le Goff Wilfried, Sposito Andrei C
Cardiology Division, Atherosclerosis and Vascular Biology Laboratory (AtheroLab), State University of Campinas (Unicamp), Campinas 13083-887, Brazil.
Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, F-75006 Paris, France.
Metabolites. 2021 Nov 28;11(12):807. doi: 10.3390/metabo11120807.
Type 2 diabetes mellitus and insulin resistance feature substantial modifications of the lipoprotein profile, including a higher proportion of smaller and denser low-density lipoprotein (LDL) particles. In addition, qualitative changes occur in the composition and structure of LDL, including changes in electrophoretic mobility, enrichment of LDL with triglycerides and ceramides, prolonged retention of modified LDL in plasma, increased uptake by macrophages, and the formation of foam cells. These modifications affect LDL functions and favor an increased risk of cardiovascular disease in diabetic individuals. In this review, we discuss the main findings regarding the structural and functional changes in LDL particles in diabetes pathophysiology and therapeutic strategies targeting LDL in patients with diabetes.
2型糖尿病和胰岛素抵抗的特征是脂蛋白谱有显著改变,包括比例更高的更小、密度更大的低密度脂蛋白(LDL)颗粒。此外,LDL的组成和结构发生了质性变化,包括电泳迁移率的改变、LDL中甘油三酯和神经酰胺的富集、修饰的LDL在血浆中保留时间延长、巨噬细胞摄取增加以及泡沫细胞的形成。这些改变影响LDL的功能,并增加糖尿病个体患心血管疾病的风险。在这篇综述中,我们讨论了关于糖尿病病理生理学中LDL颗粒的结构和功能变化的主要发现,以及针对糖尿病患者LDL的治疗策略。